Nicotine, Botulinum toxin, Curare, Atropine, and Barbiturates all impact which neurotransmitter?

Prepare for the Drugs and Human Behavior Test. Study with flashcards and multiple choice questions. Each question includes hints and detailed explanations, ensuring you're ready to excel in your exam!

Multiple Choice

Nicotine, Botulinum toxin, Curare, Atropine, and Barbiturates all impact which neurotransmitter?

Explanation:
The common thread here is acetylcholine signaling. Each of these substances affects acetylcholine in a different way, either by changing its action at receptors, its release, or the overall level of cholinergic activity. Nicotine acts by activating nicotinic acetylcholine receptors, directly enhancing cholinergic transmission at those sites, especially in brain circuits and at the neuromuscular junction. Botulinum toxin blocks the release of acetylcholine from nerve endings by cleaving SNARE proteins needed for vesicle fusion, so fewer ACh molecules reach the synapse and signaling drops. Curare binds to nicotinic acetylcholine receptors at the neuromuscular junction and prevents acetylcholine from activating them, leading to reduced muscle contraction. Atropine blocks muscarinic acetylcholine receptors, preventing acetylcholine from exerting its effects on those receptors, which alters parasympathetic signaling and some central effects. Barbiturates are primarily GABAergic and produce CNS depression, but their overall effect dampens neuronal activity, which can lower cholinergic transmission in various brain networks. So, despite their diverse actions, these drugs all influence acetylcholine pathways in some direct or indirect manner.

The common thread here is acetylcholine signaling. Each of these substances affects acetylcholine in a different way, either by changing its action at receptors, its release, or the overall level of cholinergic activity.

Nicotine acts by activating nicotinic acetylcholine receptors, directly enhancing cholinergic transmission at those sites, especially in brain circuits and at the neuromuscular junction. Botulinum toxin blocks the release of acetylcholine from nerve endings by cleaving SNARE proteins needed for vesicle fusion, so fewer ACh molecules reach the synapse and signaling drops. Curare binds to nicotinic acetylcholine receptors at the neuromuscular junction and prevents acetylcholine from activating them, leading to reduced muscle contraction. Atropine blocks muscarinic acetylcholine receptors, preventing acetylcholine from exerting its effects on those receptors, which alters parasympathetic signaling and some central effects. Barbiturates are primarily GABAergic and produce CNS depression, but their overall effect dampens neuronal activity, which can lower cholinergic transmission in various brain networks.

So, despite their diverse actions, these drugs all influence acetylcholine pathways in some direct or indirect manner.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy